REVTORPYK
Live / Registered — Registered (as of 10 Nov 2026)
What this means for you
Registered since 10 Nov 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Nov 2032: the §8 declaration of use).
Record
- Serial number
- 99296198
- Registration number
- 8545082
- Mark type
- Word mark
- Filed
- 22 Jul 2025
- Published for opposition
- 06 Jan 2026
- Registered
- 10 Nov 2026
- Next maintenance filing
- §8 declaration of use, due by 10 Nov 2032 (grace period to 10 May 2033)
- Attorney of record
- Anthony A Laurentano
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparation for the treatment of cancer in humans
Owner
- Celcuity Inc., Minneapolis, MN, US
- Celcuity Inc., Minneapolis, MN, US
- Celcuity Inc., Minneapolis, MN, US
Prosecution history
- 10 Nov 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 10 Nov 2026 — REGISTERED-PRINCIPAL REGISTER
- 19 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 19 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Oct 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Oct 2026 — USE AMENDMENT FILED
- 01 Oct 2026 — TEAS STATEMENT OF USE RECEIVED
- 22 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Aug 2026 — SOU EXTENSION 1 GRANTED
- 21 Aug 2026 — SOU EXTENSION 1 FILED
- 21 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jan 2026 — PUBLISHED FOR OPPOSITION
- 31 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED